Sucralfate USP For Compounding (API)

Sucralfate USP for Compounding (API) is an active pharmaceutical ingredient used in the formulation of customized medications primarily for the treatment of gastrointestinal conditions. It is especially effective in managing and treating ulcers in the gastrointestinal tract, such as peptic ulcers. Sucralfate works by forming a protective barrier on the ulcer site, which shields it from stomach acid and allows healing. It can also be used to treat other conditions that require protection of the mucosal lining. Compounding with sucralfate allows for the preparation of tailored dosage forms to meet specific patient needs, enhancing compliance and therapeutic outcomes.

Sucralfate USP is an active pharmaceutical ingredient (API) used in the treatment of ulcers and other gastrointestinal disorders. It belongs to a class of medication known as cytoprotective agents, which work by forming a protective barrier over the damaged areas of the stomach or intestines, allowing them to heal. Sucralfate works by binding to proteins in the ulcer site, creating a coating that protects it from stomach acid and enzymes. This helps to promote the healing process and relieve symptoms such as pain, indigestion, and heartburn. Sucralfate USP is a salt of the aluminum complex of sucrose octasulfate and is available as tablets, suspension, and enema for oral and rectal use. Other inactive ingredients may also be included in the formulation to improve the taste, stability, and absorption of the medication.

Sucralfate USP for compounding is used to formulate topical medications for the treatment of ulcers and other gastrointestinal conditions. It is a cytoprotective agent that helps create a protective layer over damaged tissues in the digestive tract, allowing them to heal and reducing symptoms such as pain and inflammation. This medication can also be compounded into a liquid or suspension for oral administration to treat these conditions.

CAS Number: 54182-58-0